Nicotinic Acid → HCID 66706738, 화합물

반응식

[C:1]([OH:9])(=O)[C:2]1[CH:7]=[CH:6][CH:5]=[N:4][CH:3]=1.[NH2:10][CH2:11][CH2:12][O:13][C:14]1[C:24]2[CH2:23][CH2:22][N:21](C(=O)C(F)(F)F)[CH2:20][CH2:19][C:18]=2[CH:17]=[CH:16][C:15]=1[Cl:31]>>[ClH:31].[Cl:31][C:15]1[CH:16]=[CH:17][C:18]2[CH2:19][CH2:20][NH:21][CH2:22][CH2:23][C:24]=2[C:14]=1[O:13][CH2:12][CH2:11][NH:10][C:1]([C:2]1[CH:3]=[N:4][CH:5]=[CH:6][CH:7]=1)=[O:9]

참가 물질

반응물 2

HCID 938Nicotinic Acid

HCID 57655967HCID 57655967, 화합물

생성물 1

HCID 66706738HCID 66706738, 화합물수율 185%

실험 절차

Use a method similar to Example 42, using nicotinic acid (40 mg, 0.327 mmol) and 6-(2-amino-ethoxy)-7-chloro-3-(2,2,2-trifluoroacetyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine (100 mg, 0.297 mmol) to give the title compound as a solid (105 mg, 93%). MS (ES+) m/z: 346 (M+H)+.

출처 및 근거

ORD 기록: ord-bd56ac99a6444c0ca86aecb3e59541af
출처 데이터셋: uspto-grants-2011_09
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US08022062B2

반응 노트

불러오는 중…